| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-15 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-14 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-14 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-13 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-12 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-11 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-11 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-11 |